Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-chain Fv radioimmunotargeting.
Huston JS, George AJ, Adams GP, Stafford WF, Jamar F, Tai MS, McCartney JE, Oppermann H, Heelan BT, Peters AM, Houston LL, Bookman MA, Wolf EJ, Weiner LM. Huston JS, et al. Among authors: bookman ma. Q J Nucl Med. 1996 Sep;40(3):320-33. Q J Nucl Med. 1996. PMID: 8961808 Review.
Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptides.
McCartney JE, Tai MS, Hudziak RM, Adams GP, Weiner LM, Jin D, Stafford WF 3rd, Liu S, Bookman MA, Laminet AA, et al. McCartney JE, et al. Among authors: bookman ma. Protein Eng. 1995 Mar;8(3):301-14. doi: 10.1093/protein/8.3.301. Protein Eng. 1995. PMID: 7479692
Optimization of in vivo tumor targeting in SCID mice with divalent forms of 741F8 anti-c-erbB-2 single-chain Fv: effects of dose escalation and repeated i.v. administration.
Adams GP, McCartney JE, Wolf EJ, Eisenberg J, Tai MS, Huston JS, Stafford WF 3rd, Bookman MA, Houston LL, Weiner LM. Adams GP, et al. Among authors: bookman ma. Cancer Immunol Immunother. 1995 May;40(5):299-306. doi: 10.1007/BF01519629. Cancer Immunol Immunother. 1995. PMID: 7600561 Free PMC article.
Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapy.
Schilder RJ, Gallo JM, Millenson MM, Bookman MA, Weiner LM, Rogatko A, Rogers B, Padavic-Shallers K, Boente M, Rosenblum N, Adams AL, Ciccotto S, Ozols RF. Schilder RJ, et al. Among authors: bookman ma. J Clin Oncol. 2001 Feb 15;19(4):1183-94. doi: 10.1200/JCO.2001.19.4.1183. J Clin Oncol. 2001. PMID: 11181685 Clinical Trial.
Biologic therapies for gynecologic cancer.
Bookman MA. Bookman MA. Curr Opin Oncol. 1995 Sep;7(5):478-84. doi: 10.1097/00001622-199509000-00015. Curr Opin Oncol. 1995. PMID: 8541395 Review.
181 results